Henry Schein Inc (HSIC) options are exhibiting high volume, with 10,081 contracts traded today, representing 58.3% of its average daily trading volume; notably, the $75 strike call option expiring July 18, 2025, saw significant activity. Similarly, Avidity Biosciences Inc (RNA) options volume reached 7,981 contracts, or 57.5% of its average daily volume, with the $30 strike put option expiring June 20, 2025, being particularly active.
Henry Schein Inc. (HSIC) has demonstrated notable options market activity, with 10,081 contracts traded, representing approximately 1.0 million underlying shares. This volume constitutes a significant 58.3% of HSIC's average daily stock trading volume of 1.7 million shares. A considerable concentration of this activity, specifically 5,004 contracts, was observed in the $75 strike call option expiring July 18, 2025, suggesting focused bullish sentiment or strategic hedging around this price level for that future date. Similarly, Avidity Biosciences Inc. (RNA) experienced heightened options trading, with 7,981 contracts changing hands, equivalent to roughly 798,100 underlying shares, or 57.5% of its 1.4 million share average daily volume. For RNA, pronounced activity was evident in the $30 strike put option expiring June 20, 2025, with 4,007 contracts traded, indicating potential bearish bets or downside protection strategies being implemented for this specific strike and expiration. While this elevated options volume relative to typical share turnover in both HSIC and RNA points to increased strategic positioning, the overall market sentiment for these stocks is reported as neutral, and the market impact score is low at 0.2, implying these are more isolated, name-specific observations rather than indicators of broad market-moving events.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
